Natural Product (NP) Details
General Information of the NP (ID: NP5204) | |||||
---|---|---|---|---|---|
Name |
Tanshinone I
|
||||
Synonyms |
Tanshinone I; 568-73-0; Tanshinone A; Tanshinon I; Tanshinone; 1,6-Dimethylphenanthro[1,2-b]furan-10,11-dione; Tanshinone-I; UNII-03UUH3J385; C18H12O3; 1,6-dimethylnaphtho[1,2-g][1]benzofuran-10,11-dione; MLS000697676; 03UUH3J385; 1,6-Dimethyl-phenanthro[1,2-b]furan-10,11-dione; 1,6-dimethylnaphtho[1,2-g]benzofuran-10,11-dione; MFCD00210563; Phenanthro[1,2-b]furan-10,11-dione, 1,6-dimethyl-; SMR000445578; 1,6-Dimethylphenanthro(1,2-b)furan-10,11-dione; Phenanthro(1,2-b)furan-10,11-dione, 1,6-Dimethyl-; Tanshinquinone I; Tanshinone I,(S); TRISTEARYLORTHOFORMATE; MLS006011773; SCHEMBL244391; CHEMBL363535; cid_114917; AIGAZQPHXLWMOJ-UHFFFAOYSA-; BDBM51317; DTXSID90972247; Tanshinone I, analytical standard; CHEBI:149906; HMS2222J14; HMS3656A11; Tanshinone I, >=98% (HPLC); BCP28292; HY-N0134; ZINC2558154; BBL010133; s2364; STK801472; AKOS005613012; AC-7999; CCG-267206; MCULE-4980744982; NCGC00247624-01; NCGC00247624-02; NCGC00247624-03; NCGC00247624-05; AK168189; AS-68049; DB-052982; FT-0632407; N1845; SW219821-1; V1541; 568T730; A831218; Q-100655; 1,6-dimethylnaphtho[1,2-g]benzofuran-10,11-quinone; 1,6-Dimethylphenanthro[1,2-b]furan-10,11-dione #; Q27247588; 1,6-dimethyl-10H,11H-phenanthro[1,2-b]furan-10,11-dione
Click to Show/Hide
|
||||
Species Origin | Salvia miltiorrhiza ... | Click to Show/Hide | |||
Salvia miltiorrhiza | |||||
Disease | Ovarian cancer [ICD-11: 2C73] | Investigative | [1] | ||
Structure |
![]() |
Click to Download Mol2D MOL |
|||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C18H12O3
|
||||
PubChem CID | |||||
Canonical SMILES |
CC1=C2C=CC3=C(C2=CC=C1)C(=O)C(=O)C4=C3OC=C4C
|
||||
InChI |
1S/C18H12O3/c1-9-4-3-5-12-11(9)6-7-13-15(12)17(20)16(19)14-10(2)8-21-18(13)14/h3-8H,1-2H3
|
||||
InChIKey |
AIGAZQPHXLWMOJ-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 568-73-0
|
||||
ChEBI ID | |||||
Herb ID | |||||
SymMap ID | |||||
TCMSP ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Lenalidomide | Multiple myeloma | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
Molecule(s)
Regulation |
Down-regulation | Expression | ACD | Molecule Info | ||
Down-regulation | Expression | TERF2IP | Molecule Info | |||
Down-regulation | Expression | TNKS-1 | Molecule Info | |||
In-vitro Model | RPMI-8226 | CVCL_0014 | Plasma cell myeloma | Homo sapiens | ||
U266B1 | CVCL_0566 | Plasma cell myeloma | Homo sapiens | |||
Experimental
Result(s) |
Combination of TanI with standard chemotherapeutic drug Len, potentiates cell death in myeloma cells. |


